Compound Evidence File
#EC-2026-0028
NPP (N-phenethyl-4-piperidone) CAS 39742-60-4
Filed under Raw Materials. The bureau holds 57 laboratory returns for this compound from 14 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
14 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 9.4 | 9.4 | 9.4 | 13 Feb 2025 | 13 Feb 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 9.3 | 8.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.8 | 7.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 8.7 | 8.7 | 8.7 | 14 Jan 2025 | 14 Jan 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 8.5 | 7.5 | 10.0 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.4 | 7.1 | 9.1 | 24 May 2026 | 24 May 2026 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 8.1 | 8.1 | 8.1 | 3 Jun 2025 | 3 Jun 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 7.8 | 7.1 | 9.4 | 21 May 2026 | 21 May 2026 |
| UtherCASE #VI-2026-0902 | X | 6 | 7.2 | 4.3 | 10.0 | 2 Apr 2025 | 19 Jan 2026 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 6 | 6.5 | 4.4 | 9.3 | 28 Mar 2025 | 24 May 2026 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 5.3 | 5.3 | 5.3 | 20 Jun 2025 | 20 Jun 2025 |
| Pure RawzCASE #VI-2026-0767 | X | 2 | 5.2 | 5.1 | 5.4 | 25 Apr 2025 | 19 Jan 2026 |
Open any subject to view the batch-level evidence for NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 alone.